Search Results for 'Vaccine'
Contract Service Directory Companies
Microsite Companies
Featured Companies
View All Buyers Guide Companies »
Contract Service Directory Categories
View All Categories »
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
CureVac and Wacker Sign Contract for Manufacturing of Covid-19 Vaccine Candidate
Manufacturing at Wacker’s biotech site in Amsterdam is scheduled to start in the first half of 2021.Contract Pharma Staff 11.24.20
-
Biologics, Proteins, Vaccines | Cold Chain Management | Logistics | Supply Chain
Rising to The Occasion: The High Stakes of Vaccine Transport
How logistical precision can ensure safe and efficient delivery of the COVID-19 vaccine.Bill Brooks, Vice President of North America Transportation Portfolio at Capgemini 11.04.20
-
cGMP Manufacture | Fill/Finish | Scale-up/Technology Transfer
Ramping Up COVID-19 Vaccine Fill and Finish Capacity
As a partner to the U.S. Government, GRAM's newest facility was designed to increase large-scale fill and finish capacity with room to expand as demand grows.Online Exclusives Kristin Brooks, Contract Pharma 11.03.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Industry News
iBio Advances COVID-19 Vaccine Candidate
IBIO-201 induced the production of anti-spike neutralizing antibodies in tests.Contract Pharma Staff 09.10.20
-
Biologics, Proteins, Vaccines | Drug Development | Regulatory Affairs
Expediting a COVID-19 Vaccine: FDA Approval Process
The pressures of the pandemic are pushing sponsors and FDA to look at both efficacy and speed in developing a vaccine.Kristin Brooks, Managing Editor 09.09.20
-
Logistics | Supply Chain
Is Blockchain Key to COVID-19 Vaccine Distribution?
The global supply chain has taken a huge hit over the last several months, what role might blockchain play when it comes to vaccine distribution.Online Exclusives Kristin Brooks, Contract Pharma 08.05.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
AstraZeneca Takes Next Steps Towards Broad Access to Oxford’s COVID-19 Vaccine
Agreements with CEPI and Gavi and the Serum Institute of India will bring vaccine to low and middle-income countries and beyondContract Pharma Staff 06.08.20
-
Biologics, Proteins, Vaccines | Drug Development | Information Technology
Speeding Vaccine Development with Advanced Analytics
Having immediate access to wide ranging resources of data can help speed the COVID-19 vaccine development processDr. Shlomi Madar, VP of Healthcare Solutions, Signals Analytics 04.15.20
-
Biologics, Proteins, Vaccines | Parenterals
Seasonal Vaccine Manufacturing
Experience can increase speed and assurance of delivery.Wendy Saffell-Clemmer, Lead Scientist, R&D, Senior Director Baxter Pharmaceuticals & Baxter Biopharma Solutions 05.07.19
-
